Search research articles
Contact Us
Filters
Showing results (111-120 of 127) with videos related to
Page
of 13
Sort By:
Cell Reports. Medicine
|
May 2, 2022
AXL targeting restores PD-1 blockade sensitivity of <i>STK11/LKB1</i> mutant NSCLC through expansion of TCF1<sup>+</sup> CD8 T cells
Huiyu Li, Zhida Liu, Longchao Liu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 21, 2012
Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study
Erik Thunnissen, Mary Beth Beasley, Alain C Borczuk, et al.
Nature Communications
|
April 27, 2025
Improved overall survival in an anti-PD-L1 treated cohort of newly diagnosed glioblastoma patients is associated with distinct immune, mutation, and gut microbiome features: a single arm prospective phase I/II trial
Shiao-Pei Weathers, Xiqi Li, Haifeng Zhu, et al.
Oncoimmunology
|
February 24, 2025
Molecular and immunological features associated with long-term benefits in metastatic NSCLC patients undergoing immune checkpoint blockade
Pedro Rocha, Rafael Bach, Laura Masfarré, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 21, 2018
Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer
Yasushi Yatabe, Sanja Dacic, Alain C Borczuk, et al.
Research Square
|
May 27, 2024
The evolution of lung adenocarcinoma precursors is associated with chromosomal instability and transition from innate to adaptive immune response/evasion
Xin Hu, Bo Zhu, Natalie Vokes, et al.
Cell Reports. Medicine
|
March 12, 2024
Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept
Morteza Salehjahromi, Tatiana V Karpinets, Sheeba J Sujit, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 13, 2023
International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy
Sanja Dacic, William Travis, Mary Redman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 1, 2020
IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy
William D Travis, Sanja Dacic, Ignacio Wistuba, et al.
Nature Communications
|
April 5, 2022
MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers
Omar Alhalabi, Jianfeng Chen, Yuxue Zhang, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 127) with videos related to
Sort By:
Page
of 13
Cell Reports. Medicine
|
May 2, 2022
AXL targeting restores PD-1 blockade sensitivity of <i>STK11/LKB1</i> mutant NSCLC through expansion of TCF1<sup>+</sup> CD8 T cells
Huiyu Li, Zhida Liu, Longchao Liu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 21, 2012
Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study
Erik Thunnissen, Mary Beth Beasley, Alain C Borczuk, et al.
Nature Communications
|
April 27, 2025
Improved overall survival in an anti-PD-L1 treated cohort of newly diagnosed glioblastoma patients is associated with distinct immune, mutation, and gut microbiome features: a single arm prospective phase I/II trial
Shiao-Pei Weathers, Xiqi Li, Haifeng Zhu, et al.
Oncoimmunology
|
February 24, 2025
Molecular and immunological features associated with long-term benefits in metastatic NSCLC patients undergoing immune checkpoint blockade
Pedro Rocha, Rafael Bach, Laura Masfarré, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 21, 2018
Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer
Yasushi Yatabe, Sanja Dacic, Alain C Borczuk, et al.
Research Square
|
May 27, 2024
The evolution of lung adenocarcinoma precursors is associated with chromosomal instability and transition from innate to adaptive immune response/evasion
Xin Hu, Bo Zhu, Natalie Vokes, et al.
Cell Reports. Medicine
|
March 12, 2024
Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept
Morteza Salehjahromi, Tatiana V Karpinets, Sheeba J Sujit, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 13, 2023
International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy
Sanja Dacic, William Travis, Mary Redman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 1, 2020
IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy
William D Travis, Sanja Dacic, Ignacio Wistuba, et al.
Nature Communications
|
April 5, 2022
MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers
Omar Alhalabi, Jianfeng Chen, Yuxue Zhang, et al.
Page
of 13